4//SEC Filing
Seymour Albert 4
Accession 0000899243-23-000629
CIK 0001661998other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:35 PM ET
Size
11.4 KB
Accession
0000899243-23-000629
Insider Transaction Report
Form 4
Seymour Albert
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2023-01-01+4,290→ 139,856 total - Exercise/Conversion
Restricted Stock Units
2023-01-01−4,290→ 4,420 total→ Common Stock (4,290 underlying) - Exercise/Conversion
Restricted Stock Units
2023-01-01−6,930→ 14,070 total→ Common Stock (6,930 underlying) - Exercise/Conversion
Common Stock
2023-01-01+6,930→ 146,786 total
Footnotes (4)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]Includes 3,920 shares acquired under Issuer's Employee Stock Purchase Plan on August 31, 2022.
- [F3]The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date.
- [F4]The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date.
Documents
Issuer
Homology Medicines, Inc.
CIK 0001661998
Entity typeother
Related Parties
1- filerCIK 0001735324
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:35 PM ET
- Size
- 11.4 KB